Nan Fung Group
Hong Kongnanfung.com
Overview
Nan Fung Group is a privately held conglomerate headquartered in Hong Kong with global interests in real estate development and investment, which holds a well-diversified and substantial financial investment portfolio.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Asian University Basketball League | Apr 2026 | Series A | Co-investor |
| BioAge Labs | Feb 2024 | Series D | - |
| Arkuda Therapeutics | Feb 2022 | Series B | Lead |
| Ablaze Pharmaceuticals | Nov 2021 | Series A | - |
| HotSpot Therapeutics | Nov 2021 | Series C | Lead |
Key People
Vanessa Cheung
Managing Director (Hong Kong Property)
Lisa Cai
Portfolio Manager - Pivotal Life Sciences
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
